Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 15664806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptor.

  2003cited by this paper
• Function of prostanoid receptors: studies on knockout mice.

  2002cited by this paper
• Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP(3) prostanoid receptor.

  2002cited by this paper
• Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor.

  2001cited by this paper
• Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.

  2001cited by this paper
• The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

  2000cited by this paper
• Distribution and function of prostanoid receptors: studies from knockout mice.

  2000cited by this paper
• Synthesis and structure-activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1.

  2000cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999cited by this paper
• Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.

  1997cited by this paper
• Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

  1995cited by this paper

• Prostanoid receptors in GtoPdb v.2025.3

  2025cites this paper
• Synthesis of Bio-Inspired 1,3-Diarylpropene Derivatives via Heck Cross-Coupling and Cytotoxic Evaluation on Breast Cancer Cells

  2022cites this paper
• EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

  2021cites this paper
• Prostanoid receptors in GtoPdb v.2021.2

  2021cites this paper
• Enantiospecific Total Synthesis and Absolute Configuration Assignment of Chabrolobenzoquinone H.

  2021cites this paper
• Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal

  2016cites this paper
• Nature of the slow relaxation of smooth muscle induced by a EP2 receptor agonist with a non-prostanoid structure.

  2013cites this paper
• Prostaglandin E2 Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin Secretion

  2013cites this paper
• Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

  2013cites this paper
• Fluorescent Human EP3 Receptor Antagonists.

  2012cites this paper
• Interaction of prostanoid EP3 and TP receptors in guinea‐pig isolated aorta: contractile self‐synergism of 11‐deoxy‐16,16‐dimethyl PGE2

  2011cites this paper
• Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011cites this paper
• 3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists.

  2010cites this paper
• 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: discovery and exploration of the carboxyamide side chain.

  2010cites this paper
• Prostanoid receptor antagonists: development strategies and therapeutic applications

  2009cites this paper
• Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.

  2009cites this paper
• Comparison between two classes of selective EP(3) antagonists and their biological activities.

  2006cites this paper